Assessment on compatibility and safety of labels for pharmaceutical packaging

J Pharm Biomed Anal. 2023 Oct 25:235:115591. doi: 10.1016/j.jpba.2023.115591. Epub 2023 Jul 20.

Abstract

Although the secondary packing materials do not directly contact the finished drug products, compound migration may still happen between them. To ensure drug quality and safety, extractables and leachables of the packing materials should be analyzed. In this study, 2,6-di-tert-butyl-4-methylphenol (BHT) was first found in the labels for pharmaceutical packaging. For the identification of the compound, a strategy combining high performance liquid chromatography (HPLC), ultra-performance liquid chromatography-quadrupole time-of-flight mass (UPLC-Q-TOF-MS) and nuclear magnetic resonance (NMR) spectroscopy was utilized. Afterwards, a effective and sensitive HPLC method for quantification of BHT was developed and validated. Finally, a toxicological risk assessment of BHT was performed to ensure the safety of drugs.

Keywords: BHT Pharmaceutical packing labels; NMR HPLC; UPLC-Q-TOF-MS.

MeSH terms

  • Chromatography, High Pressure Liquid / methods
  • Chromatography, Liquid
  • Drug Packaging* / methods
  • Pharmaceutical Preparations

Substances

  • Pharmaceutical Preparations